Table A3.
Description of glycemic control and prescription profile of patients according to their frailty phenotype.
| Nonfrail Patients (FRIED Score: 0 to 2) |
Frail Patients (FRIED Score: 3 to 5) |
p Value | |
|---|---|---|---|
| HbA1c level | n = 34 | n = 66 | |
| ≤7% | 22 (64.7%) | 34 (51.5%) | 0.35 * |
| between 7% and 8% | 6 (17.6%) | 20 (30.3%) | |
| >8% | 6 (17.6%) | 12 (18.2%) | |
| Drugs | n = 36 | n = 74 | |
| Number of glucose-lowering drugs | 1.3 ± 1.0 |
1.4 ± 1.0 |
0.79 # |
| No drugs | 7 (19.4%) | 13 (17.6%) | 0.66 * |
| OGLDs only | 19 (52.8%) | 32 (43.2%) | |
| Insulin | 5 (13.9%) | 17 (23.0%) | |
| OGLDs + Insulin | 5 (13.9%) | 12 (16.2%) |
HbA1c = glycated hemoglobin; OGLDs = oral glucose-lowering drugs, * chi-square test, # Wilcoxon test.